International Journal of Cardiology

Scope & Guideline

Advancing Cardiovascular Knowledge for a Healthier Tomorrow

Introduction

Explore the comprehensive scope of International Journal of Cardiology through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore International Journal of Cardiology in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN0167-5273
PublisherELSEVIER IRELAND LTD
Support Open AccessNo
CountryIreland
TypeJournal
Convergefrom 1981 to 2024
AbbreviationINT J CARDIOL / Int. J. Cardiol.
Frequency24 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE 00000, IRELAND

Aims and Scopes

The International Journal of Cardiology focuses on advancing the understanding and treatment of cardiovascular diseases through high-quality research. It encompasses a broad range of topics including clinical trials, epidemiological studies, and innovative therapeutic strategies.
  1. Cardiovascular Genetics and Genomics:
    Research exploring the genetic underpinnings of cardiovascular diseases, including familial syndromes and gene mutations associated with conditions like hypertrophic cardiomyopathy.
  2. Innovative Imaging Techniques:
    Utilization of advanced imaging modalities such as cardiac MRI, echocardiography, and CT angiography to assess cardiac function, structure, and disease progression.
  3. Heart Failure Management:
    Studies focusing on the diagnosis, treatment, and management strategies for various forms of heart failure, including preserved and reduced ejection fraction.
  4. Percutaneous Interventions and Surgical Techniques:
    Research on the efficacy and outcomes of minimally invasive techniques such as TAVR (transcatheter aortic valve replacement) and PCI (percutaneous coronary intervention) in treating cardiac conditions.
  5. Preventive Cardiology and Risk Assessment:
    Investigations into the prevention of cardiovascular diseases through lifestyle interventions, risk factor management, and the application of predictive models.
  6. Pharmacotherapy and Drug Development:
    Clinical trials and studies evaluating the effectiveness of new and existing pharmacological therapies for cardiovascular diseases, including antithrombotics and heart failure medications.
The journal has seen a rise in publications focusing on innovative and emerging areas of cardiovascular research, reflecting the evolving landscape of the field.
  1. Digital Health and Telemedicine:
    There is increasing interest in the role of digital health technologies and telemedicine in managing cardiovascular diseases, particularly post-COVID-19, highlighting the shift towards remote monitoring and care.
  2. Machine Learning and Artificial Intelligence:
    The application of machine learning and AI in predicting cardiovascular outcomes and personalizing treatment plans is trending, showcasing the integration of technology in cardiology.
  3. Personalized and Precision Medicine:
    Research focused on tailoring treatments based on individual genetic, phenotypic, and lifestyle characteristics is on the rise, reflecting a move towards more individualized approaches in cardiovascular care.
  4. Inflammation and Cardiovascular Disease:
    Emerging studies are increasingly recognizing the role of inflammatory processes in cardiovascular diseases, leading to research that explores new therapeutic targets.
  5. Cardio-Oncology:
    As more cancer treatments have cardiovascular implications, the intersection of cardiology and oncology is gaining prominence, with a focus on managing cardiovascular risks in cancer patients.

Declining or Waning

While the journal continues to expand its scope, certain areas have shown a decline in publication frequency or interest, reflecting shifts in research priorities and emerging trends.
  1. Traditional Risk Factor Studies:
    Research centered on conventional cardiovascular risk factors has decreased as the field shifts towards more nuanced genetic, molecular, and lifestyle factors influencing cardiovascular health.
  2. Basic Science Research:
    There is a noticeable decline in the publication of purely basic science studies, with a growing emphasis on translational research that connects laboratory findings to clinical applications.
  3. Epidemiological Studies without Intervention:
    The focus on observational epidemiological studies that do not propose interventions or solutions is waning, as the journal prioritizes studies that offer actionable insights for clinical practice.

Similar Journals

Journal fur Kardiologie

Exploring the Heart of Cardiovascular Research.
Publisher: KRAUSE & PACHERNEGG GMBHISSN: 1024-0098Frequency: 12 issues/year

The Journal fur Kardiologie, published by KRAUSE & PACHERNEGG GMBH, is a pivotal resource in the field of Cardiology and Cardiovascular Medicine. With an ISSN of 1024-0098 and an E-ISSN of 1680-936X, this journal has played a significant role in disseminating valuable research and clinical studies from 1998 until its coverage discontinuation in Scopus in 2017. Despite its Scopus rank being relatively low at #316/324 in its category, it continues to serve as a platform for emerging cardiology research. The journal’s scope encompasses various aspects of cardiovascular health, providing insights that are crucial for researchers, professionals, and students alike seeking to advance their knowledge and practice in cardiology. While the journal is not open access, its contributions to the field are essential for those looking to stay informed about the latest developments in cardiovascular medicine.

Archives of Cardiovascular Diseases

Advancing cardiovascular health through groundbreaking research.
Publisher: ELSEVIER MASSON, CORP OFFISSN: 1875-2136Frequency: 12 issues/year

The Archives of Cardiovascular Diseases, published by Elsevier Masson, stands as a leading journal in the field of cardiology and cardiovascular medicine, with an impressive impact factor that underscores its relevance and influence. This esteemed journal, recognized in the Q2 category for both cardiology and miscellaneous medicine, aims to disseminate groundbreaking research, innovative methodologies, and clinical advancements that can shape the future of cardiovascular health. With its diverse array of open access options, researchers and students alike have the ability to engage with high-quality content, ensuring that cutting-edge findings are accessible globally. Since its inception in 2008, the journal has actively contributed to the advancement of knowledge in cardiovascular diseases, fostering collaboration among clinicians, researchers, and educators. Headquartered in Paris, France, Archives of Cardiovascular Diseases remains committed to enhancing our understanding of cardiovascular health and improving patient outcomes worldwide.

Cardiovascular Innovations and Applications

Empowering healthcare professionals with the latest cardiovascular innovations.
Publisher: COMPUSCRIPTISSN: 2009-8618Frequency: 1 issue/year

Cardiovascular Innovations and Applications is a premier open-access journal dedicated to advancing knowledge in the field of cardiovascular medicine. Published by COMPUSCRIPT since 2016, this journal provides a platform for the dissemination of innovative research and applications that address crucial topics in cardiology, aiming to bridge the gap between clinical practice and cutting-edge research. With an ISSN of 2009-8618 and an E-ISSN of 2009-8782, it operates on a global scale, facilitating access to high-quality content without financial barriers. The journal is positioned within the Medicine - Cardiology and Cardiovascular Medicine category, and its current Scopus rank of #321/387 reflects its potential for growth and influence in the academic community, being in the 17th percentile. Researchers, healthcare professionals, and students will find Cardiovascular Innovations and Applications an invaluable resource in their quest for the latest findings and advancements in cardiovascular health and treatment methodologies.

Pakistan Heart Journal

Championing Evidence-Based Cardiology for All.
Publisher: PAKISTAN CARDIAC SOCISSN: 0048-2706Frequency: 4 issues/year

Pakistan Heart Journal, with the ISSN 0048-2706 and E-ISSN 2227-9199, is a premier publication by the Pakistan Cardiac Society, dedicated to advancing the field of cardiology and cardiovascular medicine. Established as an Open Access journal since 2011, it provides a valuable platform for researchers and clinicians to disseminate innovative findings and insights within this critical area of health. Based in Karachi, Pakistan, at the National Institute of Cardiovascular Diseases, this journal aims to foster an enriched understanding of cardiovascular health by publishing rigorous research, case studies, and review articles. Despite its current categorization as Q4 in the latest 2023 quartiles and a rank of 357/387 in the Scopus database, it plays a vital role in the academic community, encouraging collaborative efforts and dialogue among professionals. The journal aspires to converge diverse perspectives and innovations in cardiology from 2019 to 2024, thereby enhancing the quality and scope of cardiovascular research in the region and beyond.

Expert Review of Cardiovascular Therapy

Fostering Innovation in Cardiovascular Medicine
Publisher: TAYLOR & FRANCIS INCISSN: 1477-9072Frequency: 12 issues/year

Expert Review of Cardiovascular Therapy is a leading academic journal published by TAYLOR & FRANCIS INC, focusing on innovative and impactful research in the field of cardiovascular medicine. With an ISSN of 1477-9072 and an E-ISSN of 1744-8344, this journal serves as an essential resource for researchers, clinicians, and educators, offering a platform for the dissemination of critical advancements in cardiovascular therapy and internal medicine. Since its inception in 2003, the journal has maintained a reputable standing with a Q2 ranking in various categories including Cardiology and Cardiovascular Medicine, reflecting its influence and rigor in the field. The journal, which is based in the United Kingdom, does not currently offer Open Access options, ensuring that its content is accessible primarily to subscribers. With its commitment to high-quality, peer-reviewed articles, Expert Review of Cardiovascular Therapy is dedicated to bridging the gap between experimental research and clinical application, thereby enhancing patient care and therapeutic outcomes in cardiovascular health.

International Heart Journal

Driving Progress in Cardiology and Patient Outcomes
Publisher: INT HEART JOURNAL ASSOCISSN: 1349-2365Frequency: 6 issues/year

International Heart Journal, published by INT HEART JOURNAL ASSOC, serves as a pivotal platform for research and discourse in the fields of cardiology and cardiovascular medicine. With its ISSN 1349-2365 and E-ISSN 1349-3299, this esteemed journal is based in Japan and is located at the University of Tokyo, Graduate School of Medicine, Department of Cardiovascular Medicine. Since its inception in 2005, International Heart Journal has blossomed into a respected publication with an impact factor that signifies its growing relevance, ranking in the Q3 category of both cardiology and miscellaneous medicine as of 2023. This journal not only disseminates vital research findings but also fosters collaboration among researchers and healthcare professionals. Notable for its Open Access options, it ensures the availability of its content to a broader audience, thereby enhancing knowledge transfer and innovation in cardiovascular care. With an ongoing commitment to improve clinical practice and patient outcomes, the journal continues to be an essential resource for those dedicated to advancing the understanding of heart health and disease.

Indian Heart Journal

Pioneering Insights in Cardiovascular Medicine
Publisher: ELSEVIERISSN: 0019-4832Frequency: 6 issues/year

Indian Heart Journal, published by Elsevier, is a distinguished peer-reviewed journal dedicated to the field of cardiology and cardiovascular medicine. Founded in 1961, this journal has been a pivotal resource for researchers, healthcare professionals, and students, providing a platform for innovative studies and insights into heart health. The journal transitioned to an Open Access model in 2013, ensuring widespread dissemination of vital research findings to enhance global understanding of cardiovascular diseases. Ranked in the Q3 category for Cardiology and Cardiovascular Medicine in 2023, it holds a reputable position in the medical community, with a Scopus rank of #222 out of 387 journals in the same field, placing it in the 42nd percentile. The Indian Heart Journal strives to foster advances in clinical practice and research while addressing the unique cardiac health challenges faced in India and beyond.

Hellenic Journal of Cardiology

Empowering Heart Health Through Innovative Research
Publisher: ELSEVIERISSN: 1109-9666Frequency: 6 issues/year

The Hellenic Journal of Cardiology, a peer-reviewed open-access publication under the esteemed ELSEVIER banner, proudly represents the forefront of research in the field of Cardiology and Cardiovascular Medicine. Established in 1993 and actively publishing since then, this journal has carved a niche in disseminating high-quality research and clinical insights relevant to cardiovascular health in Greece and beyond. With an impressive Q2 ranking in both Cardiology and Cardiovascular Medicine categories as of 2023, the journal holds a commendable position at Rank #126/387 in Scopus, indicative of its critical role in advancing scientific knowledge and practice. The Hellenic Journal of Cardiology transitioned to open access in 2016, ensuring that ground-breaking research is freely accessible, fostering a global dialogue among researchers, clinicians, and students alike. Its publication frequency spans significant years, providing a continuous flow of innovative findings while addressing pressing cardiovascular issues. As the journal builds on its legacy, it aspires to enrich the academic community's understanding of cardiovascular medicine, making it an invaluable resource for anyone invested in heart health.

REVISTA ESPANOLA DE CARDIOLOGIA

Your Gateway to Cutting-Edge Cardiology Insights
Publisher: EDICIONES DOYMA S AISSN: Frequency: 12 issues/year

REVISTA ESPANOLA DE CARDIOLOGIA is a premier journal dedicated to the dynamic field of cardiology, published by EDICIONES DOYMA S A in Barcelona, Spain. With an impressive Q1 status in the Medicine (miscellaneous) category for 2023, this journal is recognized for its significant contributions to cardiovascular research, evidenced by its rank of #61 out of 387 in the Scopus database, placing it within the top 16% of journals in its field. Covering a broad range of topics within cardiology, the journal aims to disseminate high-quality research, clinical studies, and educational content, fostering knowledge sharing among researchers, clinicians, and students alike. While it does not currently offer open access, the journal maintains a commitment to advancing cardiovascular health through rigorous peer-reviewed articles. With a publication history that spans from 2013 to 2024, REVISTA ESPANOLA DE CARDIOLOGIA is an essential resource for those seeking to stay at the forefront of cardiology advancements and practices.

CARDIOLOGY CLINICS

Innovating cardiology with comprehensive reviews and expert analysis.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0733-8651Frequency: 4 issues/year

CARDIOLOGY CLINICS is a prestigious journal published by W B SAUNDERS CO-ELSEVIER INC, offering insightful and comprehensive reviews in the field of cardiology and cardiovascular medicine since its inception in 1983. With its ISSN 0733-8651 and E-ISSN 1558-2264, the journal has established a significant impact factor within the academic community, holding a Q2 ranking in both Cardiology and Cardiovascular Medicine as well as in Medicine (miscellaneous) for 2023. Located in the heart of Philadelphia, USA, it serves as a vital resource for researchers, clinicians, and students seeking to deepen their understanding of cardiovascular diseases and advancements in treatment. Although it operates under a traditional subscription model, the journal remains committed to disseminating valuable knowledge that shapes current practices and informs future research directions. As it converges towards its 2024 issues, CARDIOLOGY CLINICS continues to play an influential role in enhancing the discourse on cardiovascular health worldwide, ensuring that its audience stays at the forefront of clinical and scientific developments.